50% off Premium Yearly
It sells at 90x PE while companies selling at 20x are getting hurt. Buy on weakness.
Stock price when the opinion was issued
As of Jun 12, 2026. Market Open.
Insurance software. Earnings momentum. Loves the chart. Doesn't own yet, plans to buy in next week or so. He'd be out at $110. No dividend.
Build your watch list
Sign in to track investmentsyou care about
CNBC
RN Croft Financial Group
5i Research
Stockchase Premium
Private Wealth Management, ScotiaMcleod
It sells at 90x PE while companies selling at 20x are getting hurt. Buy on weakness.